Steven J. van Beurden

Steven J. van Beurden

Auto-generated profile, based on publicly available information

Steven J. van Beurden

Faculty of Veterinary Medicine, Department of Pathobiology, Utrecht University, Yalelaan 1, 3584 CL, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2017 in Virology Journal
Verified
Journal Article
Open access
PDF file
SBSteven J. van Beurden
Steven J. van Beurden
ABAlinda J. Berends
Alinda J. Berends
AKAnnika Krämer-Kühl
Annika Krämer-Kühl
DSDieuwertje Spekreijse
Dieuwertje Spekreijse
GCGilles Chénard
Gilles Chénard
HVHelene Verheije
Helene Verheije
Avian coronavirus infectious bronchitis virus (IBV) is a respiratory pathogen of chickens that causes severe economic losses in the poultry industry worldwide. Major advances in the study of the molecular biology of IBV have resulted from the development of reverse genetics systems for the highly attenuated, cell culture-adapted, IBV strain Beaudette. However, most IBV strains, amongst them virulent field isolates, can only be propagated in embryonated chicken eggs, and not in continuous cell lines. We established a reverse genetics system for the IBV strain H52, based on targeted RNA recombination in a two-step process. First, a genomic and a chimeric synthetic, modified IBV RNA were co-transfected into non-susceptible cells to generate a recombinant chimeric murinized (m) IBV intermediate (mIBV). Herein, the genomic part coding for the spike glycoprotein ectodomain was replaced by that of the coronavirus mouse hepatitis virus (MHV), allowing for the selection and propagation of recombinant mIBV in murine cells. In the second step, mIBV was used as the recipient. To this end a recombination with synthetic RNA comprising the 3′-end of the IBV genome was performed by introducing the complete IBV spike gene, allowing for the rescue and selection of candidate recombinants in embryonated chicken eggs. Targeted RNA recombination allowed for the modification of the 3′-end of the IBV genome, encoding all structural and accessory genes. A wild-type recombinant IBV was constructed, containing several synonymous marker mutations. The in ovo growth kinetics and in vivo characteristics of the recombinant virus were similar to those of the parental IBV strain H52. Targeted RNA recombination allows for the generation of recombinant IBV strains that are not able to infect and propagate in continuous cell lines. The ability to introduce specific mutations holds promise for the development of rationally designed live-attenuated IBV vaccines and for studies into the biology of IBV in general.

14 September 2015 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
SBSteven J. van Beurden
Steven J. van Beurden
LILonneke L. Ijsseldijk
Lonneke L. Ijsseldijk
SOSoledad R. Ordonez
Soledad R. Ordonez
CFChristine Förster
Christine Förster
GVGeert de Vrieze
Geert de Vrieze
MKMarja Kik
Marja Kik

24 December 2014 in Microbiology Resource Announcements
Verified
Journal Article
Open access
PDF file
SBSteven J. van Beurden
Steven J. van Beurden
JHJoseph Hughes
Joseph Hughes
BSBernardo Saucedo
Bernardo Saucedo
JRJolianne Rijks
Jolianne Rijks
MKMarja Kik
Marja Kik
GWGavin Wilkie
Gavin Wilkie
A ranavirus associated with mass mortalities in wild water frogs ( Pelophylax spp.) and other amphibians in the Netherlands since 2010 was isolated, and its complete genome sequence was determined. The virus has a genome of 107,772 bp and shows 96.5% sequence identity with the common midwife toad virus from Spain.

1 February 2011 in Journal of Virological Methods
Verified
Journal Article
Closed access
SBSteven J. van Beurden
Steven J. van Beurden
MVMichal A. Voorbergen-Laarman
Michal A. Voorbergen-Laarman
IRIneke Roozenburg
Ineke Roozenburg
ABAnnette Boerlage
Annette Boerlage
OHOlga L.M. Haenen
Olga L.M. Haenen
MEMarc Engelsma
Marc Engelsma